[Enzyme-inducing activities of hypolipidemic agents and ultrastructural changes of the liver elicited by clofibrate (author's transl)].
D000577:Amides / Q000494:pharmacology; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001593:Benzyl Compounds / Q000494:pharmacology; D002087:Butyrates / Q000494:pharmacology*; D002994:Clofibrate / Q000494:pharmacology*; D004790:Enzyme Induction; D005260:Female; D006168:Guinea Pigs; D008041:Linoleic Acids / Q000031:analogs & derivatives* / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000648:ultrastructure*; D051379:Mice; D008854:Microscopy, Electron; D009539:Nicotinic Acids / Q000031:analogs & derivatives* / Q000494:pharmacology; D010647:Phenyl Ethers / Q000494:pharmacology; D011409:Propylene Glycols / Q000494:pharmacology*
D000577:Amides; D000924:Anticholesteremic Agents; D001593:Benzyl Compounds; D002087:Butyrates; D008041:Linoleic Acids; D009539:Nicotinic Acids; D010647:Phenyl Ethers; D011409:Propylene Glycols; D002994:Clofibrate